CoChat

Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter

Crawford, Abbe H., Hornby, Natasha L., de la Fuente, Alerie G., Piercy, Richard J. · 2023 · BMC Neuroscience
Cited by 7

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background: Duchenne muscular dystrophy is a X-linked disease characterized by severe and progressive muscle weakness, alongside cognitive impairment and a range of neurobehavioral disorders secondary to brain dystrophin deficiency. Duchenne muscular dystrophy patients have reduced cerebral gray matter and altered white matter ultrastructure (detected by magnetic resonance imaging) compared to age-matched controls. Methods: We studied the DE50-MD canine model of Duchenne muscular dystrophy, which is deficient in full length brain dystrophin (Dp427) isoforms and has a neurocognitive phenotype. Eight DE50-MD and 6 age-matched littermate wild type male dogs underwent serial brain magnetic resonance imaging from 14 to 33 months of age. Results: Reduced regional gray matter was detected in DE50-MD dogs compared with wildtype, including the piriform lobe, hippocampus and cingulate gyrus. Lateral ventricle volume was larger in DE50-MD dogs. Differences did not progress over time. White matter volume did not differ between DE50-MD and wildtype dogs. There was no difference in brain nor cranial vault volume between DE50-MD and wildtype dogs. Conclusion: Dystrophin deficiency in the canine brain results in structural changes that likely contribute to the neurocognitive phenotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12868-023-00788-2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 37

  1. Cotton S, Voudouris NJ, Greenwood KM. Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol. 2001;43(7):497–501. · DOI · Paper page
  2. Banihani R, Smile S, Yoon G, Dupuis A, Mosleh M, Snider A, et al. Cognitive and neurobehavioral profile in boys with duchenne muscular dystrophy. J Child Neurol. 2015;30(11):1472–82. · DOI · Paper page
  3. Hendriksen JG, Vles JS. Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive–compulsive disorder. J Child Neurol. 2008;23(5):477–81. · DOI · Paper page
  4. Pane M, Messina S, Bruno C, D’Amico A, Villanova M, Brancalion B, et al. Duchenne muscular dystrophy and epilepsy. Neuromuscular Disord NMD. 2013;23(4):313–5. · DOI · Paper page
  5. Doorenweerd N, Mahfouz A, van Putten M, Kaliyaperumal R, PAC TH, Hendriksen JGM, et al. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy. Sci Rep. 2017;7(1):12575. · DOI · Paper page
  6. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 1984;81(4):1189–92. · DOI · Paper page
  7. Larcher T, Lafoux A, Tesson L, Remy S, Thepenier V, Francois V, et al. Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy. PLoS ONE. 2014;9(10): e110371. · DOI · Paper page
  8. Walmsley GL, Arechavala-Gomeza V, Fernandez-Fuente M, Burke MM, Nagel N, Holder A, et al. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping. PLoS ONE. 2010;5(1): e8647. · DOI
  9. Kornegay JN. The golden retriever model of Duchenne muscular dystrophy. Skelet Muscle. 2017;7(1):9. · DOI · Paper page
  10. Klymiuk N, Blutke A, Graf A, Krause S, Burkhardt K, Wuensch A, et al. Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle. Hum Mol Genet. 2013;22(21):4368–82. · DOI · Paper page
  11. McGreevy JW, Hakim CH, McIntosh MA, Duan D. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis Model Mech. 2015;8(3):195–213. · DOI · Paper page
  12. Crawford AH, Hildyard JCW, Rushing SAM, Wells DJ, Diez-Leon M, Piercy RJ. Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy. Dis Model Mech. 2022;15(3):dmm049291. · DOI · Paper page
  13. Kogelman B, Khmelinskii A, Verhaart I, Vliet LV, Bink DI, Aartsma-Rus A, et al. Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy. PLoS ONE. 2018;13(3): e0194636. · DOI
  14. Saoudi A, Zarrouki F, Sebrie C, Izabelle C, Goyenvalle A, Vaillend C. Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy. Dis Model Mech. 2021;14(9):dmm040028. · DOI · Paper page
  15. Doorenweerd N, Dumas EM, Ghariq E, Schmid S, Straathof CS, Roest AA, et al. Decreased cerebral perfusion in duchenne muscular dystrophy patients. Neuromuscular Disord NMD. 2017;27(1):29–37. · DOI
  16. Doorenweerd N, Straathof CS, Dumas EM, Spitali P, Ginjaar IB, Wokke BH, et al. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy. Ann Neurol. 2014;76(3):403–11. · DOI · Paper page
  17. Preethish-Kumar V, Shah A, Kumar M, Ingalhalikar M, Polavarapu K, Afsar M, et al. In Vivo evaluation of white matter abnormalities in children with duchenne muscular dystrophy using DTI. AJNR Am J Neuroradiol. 2020;41(7):1271–8. · DOI · Paper page
  18. Snow WM, Anderson JE, Jakobson LS. Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review. Neurosci Biobehav Rev. 2013;37(5):743–52. · DOI · Paper page
  19. Muntoni F, Mateddu A, Serra G. Passive avoidance behaviour deficit in the mdx mouse. Neuromuscular Disord NMD. 1991;1(2):121–3. · DOI · Paper page
  20. Sekiguchi M, Zushida K, Yoshida M, Maekawa M, Kamichi S, Yoshida M, et al. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain J Neurol. 2009;132(Pt 1):124–35. · DOI · Paper page
  21. Remmelink E, Aartsma-Rus A, Smit AB, Verhage M, Loos M, van Putten M. Cognitive flexibility deficits in a mouse model for the absence of full-length dystrophin. Genes Brain Behav. 2016;15(6):558–67. · DOI · Paper page
  22. Miranda R, Sebrie C, Degrouard J, Gillet B, Jaillard D, Laroche S, et al. Reorganization of inhibitory synapses and increased PSD length of perforated excitatory synapses in hippocampal area CA1 of dystrophin-deficient mdx mice. Cereb Cortex. 2009;19(4):876–88. · DOI · Paper page
  23. Xu S, Shi D, Pratt SJP, Zhu W, Marshall A, Lovering RM. Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS. Neuromuscular Disord NMD. 2015;25(10):764–72. · DOI · Paper page
  24. Lv SY, Zou QH, Cui JL, Zhao N, Hu J, Long XY, et al. Decreased gray matter concentration and local synchronization of spontaneous activity in the motor cortex in Duchenne muscular dystrophy. AJNR Am J Neuroradiol. 2011;32(11):2196–200. · DOI · Paper page
  25. Doorenweerd N, de Rover M, Marini-Bettolo C, Hollingsworth KG, Niks EH, Hendriksen JGM, et al. Resting-state functional MRI shows altered default-mode network functional connectivity in Duchenne muscular dystrophy patients. Brain Imaging Behav. 2021;15(5):2297–307. · DOI · Paper page
  26. Lee JS, Pfund Z, Juhasz C, Behen ME, Muzik O, Chugani DC, et al. Altered regional brain glucose metabolism in duchenne muscular dystrophy: a pet study. Muscle Nerve. 2002;26(4):506–12. · DOI · Paper page
  27. Vaillend C, Chaussenot R. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Hum Mol Genet. 2017;26(6):1041–55.
  28. Fritschy JM, Panzanelli P, Tyagarajan SK. Molecular and functional heterogeneity of GABAergic synapses. Cell Mol Life Sci CMLS. 2012;69(15):2485–99. · DOI
  29. Perronnet C, Vaillend C. Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies. J Biomed Biotechnol. 2010;2010: 849426.
  30. Darmahkasih AJ, Rybalsky I, Tian C, Shellenbarger KC, Horn PS, Lambert JT, et al. Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy. Muscle Nerve. 2020;61(4):466–74. · DOI · Paper page
  31. Pangalila RF, van den Bos GA, Bartels B, Bergen M, Stam HJ, Roebroeck ME. Prevalence of fatigue, pain, and affective disorders in adults with duchenne muscular dystrophy and their associations with quality of life. Arch Phys Med Rehabil. 2015;96(7):1242–7. · DOI
  32. Trimmer RMK, Mandy F. Understanding anxiety experienced by boys with Duchenne muscular dystrophy: a qualitative focus group study british paediatric neurology association annual Meeting Belfast. Hoboken: Blackwell Publishing Ltd; 2020.
  33. Maresh K, Papageorgiou A, Ridout D, Harrison NA, Mandy W, Skuse D, et al. Startle responses in duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency brain. J Neurol. 2022;146(1):252.
  34. Conboy V, Edwards C, Ainsworth R, Natusch D, Burcham C, Danisment B, et al. Chronic musculoskeletal impairment is associated with alterations in brain regions responsible for the production and perception of movement. J Physiol. 2021;599(8):2255–72. · DOI
  35. Liepert J, Tegenthoff M, Malin JP. Changes of cortical motor area size during immobilization. Electroencephalogr Clin Neurophysiol. 1995;97(6):382–6. · DOI · Paper page
  36. Brown ES, Woolston DJ, Frol AB. Amygdala volume in patients receiving chronic corticosteroid therapy. Biol Psychiatry. 2008;63(7):705–9. · DOI
  37. Coburn-Litvak PS, Tata DA, Gorby HE, McCloskey DP, Richardson G, Anderson BJ. Chronic corticosterone affects brain weight, and mitochondrial, but not glial volume fraction in hippocampal area CA3. Neuroscience. 2004;124(2):429–38. · DOI

Cited by

See all 7

Metadata

Authors
Crawford, A. H., Hornby, N. L., de la Fuente, A. G., & Piercy, R. J.
Venue
BMC Neuroscience
Published
2023-03-17
Volume
24
Issue
1
ISSN
1471-2202
Cited by
7
References
2
Language
en
Licence
Funders
  • Academy of Medical Sciences (SGL020\1081)
  • Wellcome Trust (CP21/00032, 101550/Z/13/Z)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter. https://app.cochat.ai/papers/10.1186/s12868-023-00788-2
The paper
Crawford, A. H., Hornby, N. L., de la Fuente, A. G., & Piercy, R. J. (2023). Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter. BMC Neuroscience. https://doi.org/10.1186/s12868-023-00788-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.